$2.71
+0.04 (+1.50%)
Open$2.70
Previous Close$2.67
Day High$2.72
Day Low$2.63
52W High$4.66
52W Low$2.54
Volume—
Avg Volume166.5K
Market Cap1.44B
P/E Ratio—
EPS$0.00
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,002.6% upside
Current
$2.71
$2.71
Target
$29.88
$29.88
$20.40
$29.88 avg
$34.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 210.72M | 180.35M | 608.59M |
| Net Income | -13,559,207 | -10,444,442 | 77.66M |
| Profit Margin | -6.4% | -6.1% | 12.8% |
| EBITDA | -21,937,253 | -17,836,691 | 120.12M |
| Free Cash Flow | — | — | 67.66M |
| Rev Growth | +16.8% | +16.8% | +15.9% |
| Debt/Equity | — | — | 0.80 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |